Faricimab

Therapeutic indications

Faricimab is indicated for:

Neovascular (wet) age-related macular degeneration (nAMD)

Population group: only adults (18 years old or older)

Exudative age-related macular degeneration

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Visual impairment due to diabetic macular oedema (DME)

Population group: only adults (18 years old or older)

Diabetic macular edema

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Visual impairment due to macular oedema secondary to retinal vein occlusion

Population group: only adults (18 years old or older)

Branch RVO or central RVO.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Faricimab is contraindicated in the following cases:

Lactation

Lactation

Active intraocular inflammation

Uveitis

Active or suspected ocular or periocular infections

at least one of
Eye infection
Infection of skin of eyelid and periocular region

Concomitant use with other anti-VEGF medicinal products

Anti-angiogenic medicinal products

Rhegmatogenous retinal detachment, stage 3 or 4 macular holes, retinal break

at least one of
Rhegmatogenous retinal detachment
Full thickness macular hole stage III
Full thickness macular hole stage IV
† Retinal defect

Patients with treatment related decrease in Best Corrected Visual Acuity (BCVA)

Reduced visual acuity

Intraocular pressure of ≥30 mmHg

Raised intraocular pressure

Subretinal haemorrhage

Subretinal hemorrhage

Intraocular surgery

Surgical procedure on eye proper

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2024: VABYSMO Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈